Navigation Links
Experimental drug to fight flu

RECENT research has shown that new compounds developed for preventing and treating the flue have shown promise in animal studies, and may require only one dose to be effective.// The compounds, known collectively as multimeric zanamivir, are based on the existing flu drug relenza, or zanamivir, which the U.S. Food and Drug administration approved in 1999 for treating influenza A and B.

Researchers reported at the International Conference on Antiviral Research in Prague that a single dose of multimeric zanamivir successfully treated mice infected with human influenza A and B.


'"/>




Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental SARS Vaccine
3. Experimental vaccine for shingles is effective
4. Experimental Blood Test May Spot Heart Attack Risk, Study Says
5. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
6. Protection against HIV and Herpes is possible with the Experimental Microbicide
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Experimental Alzheimer’s Drug curbs the disease in mic
9. New Guidelines to Be Laid While Testing Experimental Drugs
10. Experimental Drug Deals Effectively with Prostate Cancer Cells
11. Experimental Drug Causes Cytokine Storm
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... , ... From 1991 to 2012, Works of Heart raised more than one ... thanks to the generous artists, sponsors, and patrons who supported what became the Triangle’s ... to HIV/AIDS, about the Alliance of AIDS Services - Carolina, and (now) about Works ...
(Date:9/22/2018)... ... September 21, 2018 , ... Located on the fourth ... its new inpatient hospice unit on Monday, October 1. The 8,500 square-foot unit featuring ... “We are excited to partner with an organization like TGH that provides excellent, innovative ...
(Date:9/22/2018)... (PRWEB) , ... September 22, 2018 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will host its 12th annual Lymphoma Research Ride, a cycling event held each ...
(Date:9/15/2018)... ... September 14, 2018 , ... Last night, Congressional ... 2019 appropriations for Labor, Health and Human Services and Education (LHHS) and Defense. ... Prevention (TPP) Program, and $286.5 million for the Title X Family Planning Program ...
(Date:9/13/2018)... ... September 13, 2018 , ... Pulsara is honored to be represented by ... Conference on September 19-22 in Chicago. Dr. Woodson, ER Physician and Founder/CEO of ... talk titled, “Your Clinical Communication & Collaboration (CC&C) is Not Enough: Why You Need ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... , ... September 14, 2018 , ... ... the launch of “Carto.graph”. Developed in collaboration with SmithGroup, the Carto.graph collection is ... landscape. , EnviroLeather™ teamed up with SmithGroup’s healthcare interior designer, Aileen Avila-Banaag ...
(Date:9/13/2018)... ASTORIA, N.Y. (PRWEB) , ... September 13, 2018 , ... ... now open. Located at 31-57 31st St., the new arrival is called Form50 ... machine created by Sebastien Lagree called The Megaformer™ - a hybrid Pilates reformer with ...
(Date:9/13/2018)... U.K. (PRWEB) , ... September ... ... (“Atlantic Healthcare” or “Company”), a specialist pharmaceutical company focused on developing and ... the Company’s first candidate product. , The U.S. Food and Drug Administration ...
Breaking Medicine Technology: